Journal profile
Frontiers in Molecular Medicine
ISSN 2674-0095 · Frontiers Media S.A. · Switzerland
Frontiers in Molecular Medicine: fully open access; APC charged, amount not published; median 57 days to acceptance (31 articles, last 24 months); 17 articles in 2025.
Scope
Aims, scope and focus
Frontiers in Molecular Medicine is published by Frontiers Media S.A.. By OpenAlex counts of its recent articles, its largest topics are Virus-based gene therapy research, Immunotherapy and Immune Responses and CAR-T cell therapy research, together about 27% of its articles. Its main subfields are Molecular Biology. (generated from OpenAlex topic counts and CAS ranking data)
Frontiers in Molecular Medicine is a PubMed Central indexed multidisciplinary journal, that explores the mechanisms of human diseases, and advances in diagnostics using cutting-edge technologies to promote cyclical innovation for human health care. Led by Field Chief Editor Dr Masaru Katoh (National Cancer Center, Japan), this DOAJ and PubMed Central indexed journal welcomes research contributions in the various domains of molecular medicine, bridging the gap between scientific discoveries and their practical applications. The journal welcomes original research articles, comprehensive review articles, and foresighted editorials that might lead to understanding human pathologies and the development of diagnostics and therapeutics in the future. Topics include, but are not limited to: bioinformatics and artificial intelligence for molecular medicine gene and virotherapy molecular mechanisms of neurodegeneration molecular medicine and cancer treatment molecular medicine for cardiology molecular microbes, disease and mechanisms of immune response molecular pathology. Frontiers in Molecular Medicine is particularly interested in transdisciplinary approaches spanning artificial intelligence, clinical bioinformatics, complete-genome sequencing, digital imaging, engineered animal models, gene editing, liquid biopsy, patient-derived organoids, pluripotent stem cells, single-cell analyses, and spatial biology. Furthermore, studies on cancers, cardiovascular diseases, infectious diseases, and neurodegenerative diseases are representative targets of our Journal, while other rare diseases are also within scope. In particular, the journal welcomes submissions which support the advance of the UN’s Sustainable Development Goals (SDGs), notably SDG 3: ensure healthy lives and promote well-being for all at all ages. As well as original research papers, the journal welcomes brief research reports, corrections, data reports, editorials, general commentaries, hypothesis & theory, methods, mini reviews, opinions, perspectives, reviews, technology and codes. Frontiers’ journals require that manuscripts primarily comprising computational studies of public data, must include appropriate validation. Please refer to the Frontiers Standards for research methodology policy, for more information. Manuscripts not adhering to these standards will not be considered. Frontiers in Molecular Medicine is committed to advancing developments in the field of molecular medicine by allowing unrest
From the journal's Aims & Scope
Main research topics OpenAlex counts of recent articles; shares are approximate
- Virus-based gene therapy researchBiochemistry, Genetics and Molecular Biology9.9%
- Immunotherapy and Immune ResponsesImmunology and Microbiology8.5%
- CAR-T cell therapy researchMedicine8.5%
- Cancer Immunotherapy and BiomarkersMedicine6.4%
- Neuroinflammation and Neurodegeneration MechanismsNeuroscience6.4%
- RNA Interference and Gene DeliveryBiochemistry, Genetics and Molecular Biology5%
- Epigenetics and DNA MethylationBiochemistry, Genetics and Molecular Biology4.3%
- T-cell and B-cell ImmunologyImmunology and Microbiology3.6%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Not covered
Not covered by this edition.
CAS Xinrui Journal Ranking (March 2026)Not covered
Not covered by this edition.
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
DOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
PMCPublisher website
Other: EBSCO, ProQuest, Dimensions, CNKI, CLOCKSS, Crossref
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- h-index
- 16OpenAlex ·
- i10-index
- 31OpenAlex ·
- 2-year mean citedness
- 3.09OpenAlex ·
- Share of gold OA articles
- 0%LetPub ·
Volume
- Downloads per year (publisher)
- 149,100Publisher website ·
Articles by year OpenAlex count · 107 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 19 | 19 | 338 |
| 2025 | 17 | 17 | 266 |
| 2024 | 10 | 10 | 145 |
| 2023 | 30 | 30 | 69 |
| 2022 | 27 | 27 | 14 |
| 2021 | 4 | 4 | 0 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
57 daysMedian, submission to acceptance · P25–P75 22 days – 75 days
- Acceptance to online
- median 22 days (31 articles)
- Submission to online
- median 75 days
- Sample
- 31 articles with submission and acceptance dates (31 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 15 weeksLetPub ·
- Submission to publication (journal-reported)
- about 15 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | CHF 1,950 | Yes | CC BY | |
| OpenAlex | CHF 1,950 | — | — | |
| LetPub | USD 2,125 | Yes | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare3 items from the author guidelines
- Keywords
- 5–8
- Reference style
- Harvard
- Templates
- LaTeX and Word
Policy excerpts from the journal's websiteAI use, Conflicts of interest, Publication ethics, License & copyright, Open access, Peer review
- AI use Use of AI to create written or visual content
Authors should not list a generative AI technology as a co-author or author of any submitted manuscript. Generative AI technologies cannot be held accountable for all aspects of a manuscript and consequently do not meet the criteria required for authorship. If the author of a submitted manuscript has used written or visual content produced by or edited using a generative AI technology, this use mu…
Source ↗Publisher website ·- Conflicts of interest Safeguards against financial conflicts of interest
CrossMark policy Model summary
Only leading researchers acting as Associate Editors, who are not part of Frontiers' staff, can make acceptance decisions based on reviews performed by external experts acting as Community Reviewers or Reviewers. None have a financial incentive to accept articles, i.e. they are not paid for their role as Associate Editor or community Reviewer, and any award scheme is not linked to acceptances of m…
Source ↗Publisher website ·- Publication ethics
Language editing Model summary
Frontiers requires manuscripts submitted to meet international English language standards to be considered for publication.
Source ↗Publisher website ·- License & copyright Open access and copyright
Figures, tables, and images published under Creative Commons CC-BY license Model summary
All Frontiers' articles from July 2012 onwards are published with open access under the Creative Commons CC-BY license (the current version is CC-BY, version 4.0). This means that the author(s) retains copyright, but the content is free to download, distribute, and adapt for commercial or non-commercial purposes, given appropriate attribution to the original article. Upon submission, the author(s)…
Source ↗Publisher website ·- Open access Open access and copyright
Open access under Creative Commons CC-BY license Model summary
All Frontiers' articles from July 2012 onwards are published with open access under the Creative Commons CC-BY license (the current version is CC-BY, version 4.0). This means that the author(s) retains copyright, but the content is free to download, distribute, and adapt for commercial or non-commercial purposes, given appropriate attribution to the original article. Upon submission, the author(s)…
Source ↗Publisher website ·- Peer review Peer review
Our rigorous, transparent peer review process combines expert review and constructive dialogue to strengthen your manuscript.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Frontiers Media S.A.
- Country or region
- Switzerland
- Language
- English
- ISSN
- 2674-0095
- Official links
- Journal homepage ↗LetPub
- Submission system ↗Publisher website
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗LetPub
- Editorial board ↗LetPub
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Frontiers in Molecular Medicine
How long does peer review take at Frontiers in Molecular Medicine?
Based on the dates recorded on 31 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 57 days (interquartile range 22–75 days); authors report an average review time of about 15 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Frontiers in Molecular Medicine?
According to the journal's author guidelines: Keywords: 5–8; Reference style: Harvard; Templates: LaTeX and Word. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Which databases index Frontiers in Molecular Medicine?
According to LetPub and DOAJ records, Frontiers in Molecular Medicine is indexed in DOAJ. The journal's website also lists PMC; that list has not been checked against each database.
Is Frontiers in Molecular Medicine open access, and what is the APC?
Frontiers in Molecular Medicine is a fully open-access journal. APC charged, amount not published.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .